230 related articles for article (PubMed ID: 38203290)
1. The Role of miRNAs in Childhood Acute Lymphoblastic Leukemia Relapse and the Associated Molecular Mechanisms.
Barrios-Palacios D; Organista-Nava J; Balandrán JC; Alarcón-Romero LDC; Zubillaga-Guerrero MI; Illades-Aguiar B; Rivas-Alarcón AA; Diaz-Lucas JJ; Gómez-Gómez Y; Leyva-Vázquez MA
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203290
[TBL] [Abstract][Full Text] [Related]
2. A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL.
Han BW; Feng DD; Li ZG; Luo XQ; Zhang H; Li XJ; Zhang XJ; Zheng LL; Zeng CW; Lin KY; Zhang P; Xu L; Chen YQ
Hum Mol Genet; 2011 Dec; 20(24):4903-15. PubMed ID: 21926415
[TBL] [Abstract][Full Text] [Related]
3. [Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia].
Xu L; Liang YN; Luo XQ; Liu XD; Guo HX
Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):178-81. PubMed ID: 21535956
[TBL] [Abstract][Full Text] [Related]
4. Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.
Nemes K; Csóka M; Nagy N; Márk Á; Váradi Z; Dankó T; Kovács G; Kopper L; Sebestyén A
Pathol Oncol Res; 2015 Jul; 21(3):597-604. PubMed ID: 25388103
[TBL] [Abstract][Full Text] [Related]
5. Six Candidate miRNAs Associated With Early Relapse in Pediatric B-Cell Acute Lymphoblastic Leukemia.
Amankwah EK; Devidas M; Teachey DT; Rabin KR; Brown PA
Anticancer Res; 2020 Jun; 40(6):3147-3153. PubMed ID: 32487609
[TBL] [Abstract][Full Text] [Related]
6. miR-324-3p and miR-508-5p expression levels could serve as potential diagnostic and multidrug-resistant biomarkers in childhood acute lymphoblastic leukemia.
Zamani A; Fattahi Dolatabadi N; Houshmand M; Nabavizadeh N
Leuk Res; 2021 Oct; 109():106643. PubMed ID: 34147937
[TBL] [Abstract][Full Text] [Related]
7. MiRNAs in Hematopoiesis and Acute Lymphoblastic Leukemia.
Mendiola-Soto DK; Bárcenas-López DA; Pérez-Amado CJ; Cruz-Miranda GM; Mejía-Aranguré JM; Ramírez-Bello J; Hidalgo-Miranda A; Jiménez-Morales S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982511
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide identification of microRNA signatures associated with stem/progenitor cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Valiollahi E; Ribera JM; Genescà E; Behravan J
Mol Biol Rep; 2019 Feb; 46(1):1295-1306. PubMed ID: 30712246
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.
Wang Y; Li Z; He C; Wang D; Yuan X; Chen J; Jin J
Blood Cells Mol Dis; 2010 Mar; 44(3):191-7. PubMed ID: 20110180
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.
Ghodousi ES; Rahgozar S
J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
13. miRNA deregulation in childhood acute lymphoblastic leukemia: a systematic review.
Gutierrez-Camino A; Garcia-Obregon S; Lopez-Lopez E; Astigarraga I; Garcia-Orad A
Epigenomics; 2020 Jan; 12(1):69-80. PubMed ID: 31833405
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia.
Mi S; Lu J; Sun M; Li Z; Zhang H; Neilly MB; Wang Y; Qian Z; Jin J; Zhang Y; Bohlander SK; Le Beau MM; Larson RA; Golub TR; Rowley JD; Chen J
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19971-6. PubMed ID: 18056805
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA as a prognostic biomarker for survival in childhood acute lymphoblastic leukemia: a systematic review.
Rashed WM; Hamza MM; Matboli M; Salem SI
Cancer Metastasis Rev; 2019 Dec; 38(4):771-782. PubMed ID: 31807971
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of microRNA profiling data does not reveal a consensus signature for B cell acute lymphoblastic leukemia.
Longjohn MN; Squires WRB; Christian SL
Gene; 2022 May; 821():146211. PubMed ID: 35134470
[TBL] [Abstract][Full Text] [Related]
18. A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 acute lymphocytic leukemia cells.
Kotani A; Ha D; Schotte D; den Boer ML; Armstrong SA; Lodish HF
Cell Cycle; 2010 Mar; 9(6):1037-42. PubMed ID: 20237425
[TBL] [Abstract][Full Text] [Related]
19. Expression pattern of
Chu X; Wu D; Zhang C; Hu S
Scand J Clin Lab Invest; 2023 Jul; 83(4):207-211. PubMed ID: 37093849
[TBL] [Abstract][Full Text] [Related]
20. A semantics-oriented computational approach to investigate microRNA regulation on glucocorticoid resistance in pediatric acute lymphoblastic leukemia.
Chen H; Zhang D; Zhang G; Li X; Liang Y; Kasukurthi MV; Li S; Borchert GM; Huang J
BMC Med Inform Decis Mak; 2018 Jul; 18(Suppl 2):57. PubMed ID: 30066657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
